SIRT5 and cancer: To confirm the profound differences among cancer types, Wang et al. found that in colorectal cancer (CRC), overexpression of SIRT5 promotes glutamine anabolic metabolism by activating GLUD1 in a deglutarylation-dependent manner, thereby increasing CRC proliferation, survival, and xenograft tumor growth.